Clinical Trials Logo

Clinical Trial Summary

This is a prospective interventional study to determine whether the profile of volatile organic compounds (VOCs) present in exhaled air (VOLATOLOM) is reproducible in stable severe COPD (Chronic Obstructive Pulmonary Disease) patients.


Clinical Trial Description

After being informed about the study, all patients giving written informed consent and meeting the eligibility criteria will undergo 4 visits spaced 4 to 6 weeks apart. The first visit V1 will be about 45 minutes duration. The others ones (V2 to V4) will be about 30 minutes duration. All sessions will be carried out in the Pneumology Department of the Foch Hospital, volatolomics platform (Exhalomics®). Exhalation collection will be performed at each visit in order to perform the volatolom analysis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05029349
Study type Interventional
Source Hopital Foch
Contact Philippe Devillier, MD PhD
Phone 0146252791
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date September 1, 2021
Completion date May 1, 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03923660 - Ventilatory Adaptation to Concentric Versus Eccentric Exercise in Patients With Severe COPD N/A
Not yet recruiting NCT04018729 - Cell Therapy Associated With Endobronchial Valve Phase 2/Phase 3
Recruiting NCT04848012 - Efficacy of an Advanced Auto-titrating NIV in COPD N/A
Recruiting NCT03398772 - Effects of a Comprehensive Health Coaching Program in Advanced Chronic Obstructive Pulmonary Disease. N/A
Completed NCT02962999 - Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation Phase 4
Recruiting NCT04069312 - Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE) Phase 3
Completed NCT02998515 - Effects of Different Oxygen Devices in Hypoxemic COPD Patients N/A
Completed NCT04533516 - Additional Manual Therapy Over Inspiratory Muscle Training in COPD N/A